We are live on ! Find out more
JY

Jeff Yass Susquehanna International Group

AUM $1.28T
1-Year Est. Return 58.89%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
-5.25%
1 Year Est. Return
+58.89%
3 Year Est. Return
+161.44%
5 Year Est. Return
+153.95%
10 Year Est. Return
+545.54%
AUM
$578B
AUM Growth
-$88.6B
Cap. Flow
+$4.3B
Cap. Flow %
0.74%
Top 10 Hldgs %
34.17%
Holding
14,706
New
1,657
Increased
4,873
Reduced
6,001
Closed
1,835

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$1.98B
2
META icon
Meta Platforms (Facebook)
META
+$997M
3
IWM icon
iShares Russell 2000 ETF
IWM
+$860M
4
WDAY icon
Workday
WDAY
+$691M
5
AMZN icon
Amazon
AMZN
+$616M

Top Sells

Rank Stock Value
1
DIS icon
Walt Disney
DIS
+$498M
2
GDX icon
VanEck Gold Miners ETF
GDX
+$420M
3
FDX icon
FedEx
FDX
+$350M
4
VALE icon
Vale
VALE
+$340M
5
TLT icon
iShares 20+ Year Treasury Bond ETF
TLT
+$322M

Sector Composition

Rank Sector Weight
1 Miscellaneous 91.96%
2 Technology 2.07%
3 Consumer Discretionary 1.49%
4 Financials 1.12%
5 Communication Services 1.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SVFAW
12526
DELISTED
SVF Investment Corp. Warrant
SVFAW
$21K ﹤0.01%
37,962
-172
-0.5% -$126
MUDSW
12527
DELISTED
Mudrick Capital Acquisition Corporation II Warrant
MUDSW
$21K ﹤0.01%
50,000
– –
BAOS icon
12528
Baosheng Media Group
BAOS
$658K
$20K ﹤0.01%
+1,806
New +$24.6K
CRDL
12529
Cardiol Therapeutics
CRDL
$241M
$20K ﹤0.01%
+12,950
New +$21.4K
CREX icon
12530
Creative Realities
CREX
$39.8M
$20K ﹤0.01%
+8,137
New +$28.7K
SVRN
12531
OceanPal Inc
SVRN
$16.5M
– –
-1
Closed -$87.7K
RCAT icon
12532
PUT
Red Cat Holdings
RCAT
$1.42B
$20K ﹤0.01%
10,100
-134,500
-93% -$259K
REFR icon
12533
PUT
Research Frontiers
REFR
$16.9M
$20K ﹤0.01%
10,200
-21,800
-68% -$40.1K
RGLS
12534
DELISTED
Regulus Therapeutics
RGLS
$20K ﹤0.01%
+6,583
New +$17.1K
VANI icon
12535
Vivani Medical
VANI
$126M
$20K ﹤0.01%
+4,615
New +$19.4K
VSTM icon
12536
PUT
Verastem
VSTM
$668M
$20K ﹤0.01%
1,175
-1,183
-50% -$20.4K
XHG
12537
XChange TEC
XHG
$196M
$20K ﹤0.01%
+1
New +$32.8K
YVR
12538
DELISTED
Liquid Media Group Ltd. Common Shares
YVR
$20K ﹤0.01%
6,975
-5,120
-42% -$15.7K
ATNX
12539
PUT
DELISTED
Athenex, Inc. Common Stock
ATNX
$20K ﹤0.01%
1,200
-4,920
-80% -$96.3K
EXN
12540
DELISTED
Excellon Resources Inc.
EXN
$20K ﹤0.01%
+22,093
New +$18.5K
NBEV
12541
CALL
DELISTED
NewAge, Inc. Common Stock (Delaware)
NBEV
$20K ﹤0.01%
33,800
-7,400
-18% -$5.29K
GSV
12542
DELISTED
Gold Standard Ventures Corp.
GSV
$20K ﹤0.01%
45,232
+28,033
+163% +$12.1K
YDKG
12543
CALL
Yueda Digital Holding
YDKG
$5.7M
$19K ﹤0.01%
+28
New +$17K
APRE icon
12544
PUT
Aprea Therapeutics
APRE
$10.8M
$19K ﹤0.01%
510
-1,200
-70% -$49.2K
CNET icon
12545
ZW Data Action Technologies
CNET
$5.32M
$19K ﹤0.01%
1,257
-2,806
-69% -$43.1K
IKT icon
12546
Inhibikase Therapeutics
IKT
$345M
$19K ﹤0.01%
+2,126
New +$17.1K
JOB icon
12547
GEE Group
JOB
$27.9M
$19K ﹤0.01%
+35,027
New +$19.1K
IMDX
12548
PUT
Insight Molecular Diagnostics
IMDX
$140M
$19K ﹤0.01%
650
-755
-54% -$24.1K
SBEV.WS
12549
DELISTED
Splash Beverage Group, Inc. Warrants to purchase 1/40th of a share of Common Stock at an exercise price of $184.00
SBEV.WS
$19K ﹤0.01%
+19,090
New +$17.5K
SNES icon
12550
SenesTech
SNES
$5.97M
$19K ﹤0.01%
+11
New +$22.5K
500 501
502
503 504

Similar funds

Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Jeff Yass's Q1 2022 Portfolio in Review

As of Q1 2022, Jeff Yass held 14,706 positions worth $578B, down 13% from $667B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Jeff Yass's Q1 2022 filing shows 1,657 new, 4,873 increased, 6,001 reduced and 1,835 closed positions. Its largest new stake was iShares JPMorgan USD Emerging Markets Bond ETF: 1,089,723 shares worth $107M. The largest sale was Walt Disney, an estimated $498M.

By sector, the portfolio is most concentrated in Miscellaneous at 92% of assets, down from 93% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Jeff Yass's largest Q1 2022 buy was iShares JPMorgan USD Emerging Markets Bond ETF: 1,089,723 shares worth $107M.
  • Jeff Yass added most to State Street SPDR S&P 500 ETF Trust in Q1 2022, an estimated $1.98B increase.
  • Jeff Yass's biggest Q1 2022 reduction was Walt Disney, cutting an estimated $498M.
  • Jeff Yass fully exited Xilinx Inc in Q1 2022, selling an estimated $217M.
  • Jeff Yass's ten largest holdings make up 34% of its $578B portfolio in Q1 2022.
  • Jeff Yass opened 1,657 new positions and closed 1,835 in Q1 2022.
  • Jeff Yass's portfolio value fell 13% quarter-over-quarter to $578B.

Based on Susquehanna International Group's 13F filing for Q1 2022, filed 16 May 2022.